Valeant Will Release Third-Quarter 2017 Financial Results On November 7


All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call. About Valeant Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics.



from Biotech News